High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962
Top Cited Papers
- 15 December 2003
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (24) , 4483-4488
- https://doi.org/10.1200/jco.2003.03.108
Abstract
Purpose: To confirm the feasibility and estimate the efficacy of methotrexate (MTX), teniposide, carmustine, and methylprednisolone (MBVP) chemotherapy combined with radiotherapy (RT) for patients with non–AIDS-related primary CNS lymphoma (PCNSL) treated in a multicenter setting.Keywords
This publication has 34 references indexed in Scilit:
- Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesionCancer, 1996
- Leptomeningeal tumor in primarchy central nervous system lymphoma: Recognition, significance, and implicationsAnnals of Neurology, 1995
- Occult systemic Non-Hodgkin's Lymphoma (NHL) in patients initially diagnosed as Primary Central Nervous System Lymphoma (PCNSL): How much staging is enough?Journal of Neuro-Oncology, 1995
- Incidence, clinicopathological features and outcome of primary central nervous system lymphomasAnnals of Oncology, 1994
- Primary Central Nervous System LymphomaAnnals of Internal Medicine, 1993
- Intraocular LymphomaOphthalmology, 1993
- The clinical spectrum of ocular lymphomaCancer, 1993
- Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoringBritish Journal of Cancer, 1993
- Primary central nervous system lymphoma: A new clinical challengeNeurology, 1991
- Primary leptomeningeal lymphomaNeurology, 1991